Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
While the mechanism is not fully understood, BPC-157 appears to influence dopamine and serotonin systems in ways that may counteract some of the mood changes that occasionally accompany significant dietary restriction
Weight Rebound: Up to 70% regain weight after stopping, as drugs suppress appetite without fixing underlying metabolic issues
What We Know About the Risks While research specific to eating disorders is limited, the National Eating Disorders Association (NEDA) and eating disorder professionals have identified several concerning patterns: Risk of Triggering or Worsening Eating Disorders There is growing evidence that GLP-1s may trigger new eating disorders or worsen existing ones
Together, these incretins contribute significantly to insulin secretion following oral glucose intake, a phenomenon known as the incretin effect
